Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:3046-3052
Published online before print June 3, 2002, doi: 10.1161/01.CIR.0000019408.67709.B5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/25/3046    most recent
01.CIR.0000019408.67709.B5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kodani, E.
Right arrow Articles by Bolli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kodani, E.
Right arrow Articles by Bolli, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Ischemic biology - basic studies

(Circulation. 2002;105:3046.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Role of Cyclic Guanosine Monophosphate in Late Preconditioning in Conscious Rabbits

Eitaro Kodani, MD; Yu-Ting Xuan, PhD; Hitoshi Takano, MD; Ken Shinmura, MD, PhD; Xian-Liang Tang, MD; Roberto Bolli, MD

From the Experimental Research Laboratory, Division of Cardiology, University of Louisville and the Jewish Heart and Lung Institute, Louisville, Ky.

Correspondence to Roberto Bolli, MD, Division of Cardiology, University of Louisville, Louisville, KY 40292. E-mail rbolli{at}louisville.edu

Background Although NO has been shown to serve both as the trigger and the mediator of the late phase of ischemic preconditioning (PC), it is unknown whether NO acts via activation of soluble guanylate cyclase (sGC). The objective of this study was to investigate the role of sGC in late PC in conscious rabbits using the selective sGC inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ).

Methods and Results A total of 172 conscious rabbits were used. When nonpreconditioned rabbits were subjected to a sequence of 4-minute coronary occlusion/4-minute reperfusion cycles, myocardial cyclic guanosine monophosphate (cGMP) levels increased significantly at the end of the third and sixth occlusions. In rabbits preconditioned 24 hours earlier (on day 1) with six occlusion/reperfusion cycles, myocardial cGMP levels on day 2 were significantly higher than in nonpreconditioned rabbits even before ischemia but did not increase further during a second sequence of 4-minute occlusion/reperfusion cycles. Administration of ODQ before the six occlusion/reperfusion cycles on day 1 did not prevent the development of late PC against either stunning or infarction on day 2. In contrast, administration of ODQ on day 2 completely ablated the late PC effect against both stunning and infarction.

Conclusions These results indicate that enhanced synthesis of cGMP by sGC is not necessary for ischemia to trigger a late PC effect but is required for the protection to become manifest 24 hours later. This implies that NO participates in late PC via two distinct mechanisms; ie, it triggers late PC on day 1 via a cGMP-independent mechanism and it mediates late PC on day 2 via a cGMP-dependent mechanism.


Key Words: ischemia • reperfusion • guanylate cyclase • cyclic guanosine monophosphate • oxadiazoles




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. D.T. Costa, S. V. Pierre, M. V. Cohen, J. M. Downey, and K. D. Garlid
cGMP signalling in pre- and post-conditioning: the role of mitochondria
Cardiovasc Res, January 15, 2008; 77(2): 344 - 352.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, M. Mirabet, J. Inserte, and J. Soler-Soler
Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes
Cardiovasc Res, October 1, 2005; 68(1): 65 - 74.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. B. Stein, X.-L. Tang, Y. Guo, Y.-T. Xuan, B. Dawn, and R. Bolli
Delayed Adaptation of the Heart to Stress: Late Preconditioning
Stroke, November 1, 2004; 35(11_suppl_1): 2676 - 2679.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. C Kukreja, R. Ockaili, F. Salloum, and L. Xi
Sildenafil-induced cardioprotection in rabbits
Cardiovasc Res, December 1, 2003; 60(3): 700 - 701.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler
Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2170 - H2176.
[Abstract] [Full Text] [PDF]